Editorial
Complications and other concerns with intralesional injection therapy with collagenase clostridium histolyticum for Peyronie’s disease
Abstract
The article by Yafi et al. reports on a well-designed survey of Sexual Medicine Society of North America members regarding complications following intralesional injection with collagenase clostridium histolyticum (CCH) for Peyronie’s disease (PD) (1).
